HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. [electronic resource]
Producer: 20161107Description: 13004-19 p. digitalISSN:- 2219-2840
- Antimetabolites, Antineoplastic -- pharmacology
- Apoptosis -- drug effects
- Carcinoma, Pancreatic Ductal -- genetics
- Caspase 3 -- metabolism
- Caspase 7 -- metabolism
- Cell Line, Tumor
- Cell Survival -- drug effects
- Combined Modality Therapy
- Cyclooxygenase 2 -- genetics
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm
- ELAV-Like Protein 1 -- genetics
- Enzyme Activation
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Heme Oxygenase-1 -- genetics
- Humans
- Pancreatic Neoplasms -- genetics
- RNA Interference
- RNA Processing, Post-Transcriptional
- Transfection
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.